Press Releases - ProMed Pharma

Check out our latest press releases about manufacturing capabilities, our facilities, and acquisitions.

ProMed Pharma Press Release June 2026

ProMed Pharma Announces Second Dedicated Manufacturing Suite Agreement at Niagara Lane Facility New Suite Designed for Highly Potent APIs and Complex Generic Drug Products PLYMOUTH MN UNITED STATES June EINPresswire...

ProMed Pharma Press Release January 2026

ProMed Pharma Announces Agreement with Undisclosed Partner for Dedicated Manufacturing Suite at New Niagara Ln Facility Agreement further validates business model and expansion plans PLYMOUTH MN UNITED STATES January EINPresswire...

ProMed Pharma Press Release August 2025

ProMed Pharma Announces Acquisition of Manufacturing Facility from Bora Pharmaceuticals Plymouth MN August ProMed Pharma LLC a leading provider of polymer-based drug delivery solutions today announced the acquisition of a...

ProMed Pharma Press Release May 2025

ProMed Pharma Secures DEA Registration for Schedule III Controlled Substances Milestone Expands Company s Capabilities in Controlled Drug Development and Manufacturing Maple Grove MN May ProMed Pharma a leading provider...

ProMed Preclinical Press Release

ProMed Pharma announces the initiation of a preclinical rat study to assess the pharmacokinetics of a novel resorbable long-acting contraceptive implant ProMed Pharma is pleased to announce the initiation of...

ProMed Pharma Press Release April 2024

ProMed Pharma Acquires SpineThera Manufacturing Capabilities and an Option to License Intellectual Property April Plymouth MN SpineThera Inc a privately held clinical-stage pharmaceutical company focused on the development of SX...

ProMed Pharma Press Release August 2023

ProMed Pharma Celebrates -year Anniversary of New Maple Grove Development and Analytical Laboratories ProMed Pharma recently celebrated the one-year anniversary of the opening of its New Product Development and Analytical...